Edition:
United Kingdom

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

1.65USD
16 Feb 2018
Change (% chg)

$0.03 (+1.54%)
Prev Close
$1.62
Open
$1.65
Day's High
$1.65
Day's Low
$1.65
Volume
4,340
Avg. Vol
30,008
52-wk High
$2.75
52-wk Low
$1.05

Chart for

About

ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical... (more)
No analyst recommendations are available for .

Overall

Beta: 1.86
Market Cap(Mil.): $19.46
Shares Outstanding(Mil.): 12.97
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.64
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Arca Biopharma announces issuance of European patent on cardiovascular disease treatment methods

* Arca Biopharma announces issuance of European patent for treating cardiovascular diseases and conditions with a new chemical entity utilizing genetic targeting

16 Nov 2017

BRIEF-ARCA Biopharma announces third quarter financial results

* ARCA Biopharma announces third quarter 2017 financial results and provides business update

09 Nov 2017

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $36.26 +0.55
Novartis AG (NOVN.S) CHF80.80 +1.18
Merck & Co., Inc. (MRK.N) $56.29 +0.30
Roche Holding Ltd. (ROG.S) CHF225.50 +2.10
Roche Holding Ltd. (RO.S) CHF230.20 +2.60
Abbott Laboratories (ABT.N) $60.17 +0.67
Bayer AG (BAYGn.DE) €98.54 +1.15
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €64.50 +1.00
Eli Lilly and Co (LLY.N) $78.97 +0.95

Earnings vs. Estimates